Tech Company Financing Transactions
Zacharon Pharmaceuticals Funding Round
Zacharon Pharmaceuticals secured a $3.5 million Series A investment round on 11/17/2008. Investors included Avalon Ventures.
Transaction Overview
Company Name
Announced On
11/17/2008
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Series A
Investors
Proceeds Purpose
The financing, provided by Avalon Ventures LLC, and the grants position the company to advance its lead small-molecule glycan inhibitors identified with a proprietary high-throughput screening platform through safety studies into early clinical trials.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
5626 Oberlin Drive 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Zacharon Pharmaceuticals, Inc. is a biotechnology company founded to exploit opportunities to discover and develop first in class drugs that target glycans. With proprietary technology and with glycobiology expertise, Zacharon has the opportunity to dominate the field of glycan-targeted drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robin Jackman
Chief Financial Officer
Douglas Downs
Chief Scientific Officer
Shripad Bhagwat
Co-Founder
Charles Glass
VP - R & D
Brett Crawford
Browse more venture capital transactions:
Prev: 11/15/2008: Rave Wireless venture capital transaction
Next: 11/17/2008: Evogen venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs